Filter by category

Specialty

Anatomy

Tissue Type

Procedure

Brand

Upcoming events

DOWNLOAD OUR FULL TISSUE & PRODUCT CATALOG

MTF_catalogue

Download

Always Looking Beneath the Surface by Examining the Data

Advancing science to improve outcomes is what motivates us. We are constantly working to improve what we do–driven by the passion to move the science of wound healing forward. Published papers continue to tell our story of success which results in restoring people's lives. 

Publications

Publications

AMNIOBAND MEMBRANE: DiDomenico et al, International Wound Journal 2018.
AMNIOBAND MEMBRANE: DiDomenico et al, Wounds 2017.
AMNIOBAND MEMBRANE: DiDomenico et al, Plastic and Reconstructive Surgery - Global Open 2016.
ALLOPATCH PLIABLE: Zelen et al, International Wound Journal 2018.
ALLOPATCH PLIABLE: Zelen et al, International Wound Journal 2016.
ALLOPATCH PLIABLE: Zelen et al, Wounds 2016.
ALLOPATCH PLIABLE: Dasgupta et al, Plastic and Reconstructive Surgery - Global Open 2016.

Case Studies

MTF Biologics Wound Care tissue forms have been designed to address a wide variety of wounds.
Please select any of the case studies presented below to learn more about our successes in application.

Case Studies

Use of AmnioBand™ Membrane, a Human Amniotic Membrane Allograft, in the Management of Chronic Non-Healing Diabetic Foot Ulcers Case
Use of AlloPatch® Pliable, a Human Acellular Dermal Matrix, as an Adjunctive Therapy for Chronic Non-Healing Diabetic Foot Ulcers

Technique Guides

Technique quides

AlloPatch Pliable
AmnioBand Membrane
AmnioBand Particulate
AmnioBand Viable

Scientific Posters

We have presented our findings at conferences and meetings across the country. Click on any of the items below to view and download scientific studies of our tissue forms in easy-to-reference posters.

Posters

Aseptically Processed Dehydrated Human Amniotic Particulate Allografts Promote Granulation Activities that Support Wound Healing.
A Prospective, Randomized, Controlled, Multi-center, Clinical Trial Examining Healing Rates, Safety, and Cost to Closure of An Acellular Reticular Allogenic Human Dermis Versus Standard of Care in the Treatment of Chronic Diabetic Foot Ulcers
A Novel Aseptically Processed Human Reticular Dermis Promotes Fibroblast Secretion of Growth Factors that Support Angiogenesis and Epithelialization in Wound Healing.
A Novel Design of Aseptically Processed Human Reticular Dermis Promotes Enhanced Cell Attachment, Proliferation and New Matrix Deposition in Wound Healing.
Aseptic Processing of Human Allogeneic Dermis Provides a Natural Scaffold with a Biocompatible Environment Conducive of Cell Attachment and Infiltration.
Terminal sterilization negatively affects dehydrated human amnion/chorion biological properties while aseptic tissue processing preserves the natural matrix structure and composition.
Aseptically Processed Dehydrated Human Amnion/Chorion Allografts Promote Proliferation, Migration and New Matrix Deposition of Type II Diabetic Keratinocytes.
Aseptically Processed Dehydrated Human Amnion/Chorion Allografts Possess Anti-microbial, Anti-inflammatory and Non-immunogenic Properties that Support Wound Healing.
Aseptically Processed Dehydrated Human Amnion/Chorion Allografts Promote Cell Attachment, Proliferation, New Matrix Deposition and In Vitro Angiogenesis That Supports Wound Healing.
Aseptically Processed Cryopreserved Amnion Tissue Preserves Essential Bioactive Components that Support the Progression of the Wound Healing Cascade.
Aseptically Processed Dehydrated Human Amnion/Chorion Allograft Promotes Healing of Chronic Wounds in a Diabetic Swine Model.